Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 14918101000001119 | Hydroxyapatite (substance) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 14918201000001114 | Hydroxyapatite | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) | Has active ingredient | False | Hydroxyapatite | Inferred relationship | Existential restriction modifier | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Hydroxyapatite | Inferred relationship | Existential restriction modifier | |
| Ossopan 800 tablets (Sanofi-Synthelabo Ltd) | Has active ingredient | False | Hydroxyapatite | Inferred relationship | Existential restriction modifier | |
| Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) | Has active ingredient | False | Hydroxyapatite | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR